NCT02477215: A trial that was reported late by Parameswaran Hari
This trial has reported, although it was 104 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02477215 |
|---|---|
| Title | Phase I/II Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 9, 2015 |
| Completion date | May 2, 2018 |
| Required reporting date | May 2, 2019, midnight |
| Actual reporting date | Aug. 14, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 104 |